Amethod wasdeveloped using liquid chromatography linked to atmospheric pressure ionization-tandem mass spectrometry (LC-MS-MS) for the measurement of the opiates, morphine, codeine, 6-monoacetylmorphine (6-MAM), acetylcodeine (AC), and heroin in oralfluid collected from patients attending a substance abuse clinic. Of the 513oralfluid samples tested, 297 showed detectable concentrations of 1 or more of the opiates and their respective percentage incidence being morphine (97%), codeine (82%), 6-MAM (77%), acetylcodeine (55%), and heroin (45%). Ahigh percentage ofthese opiate-positive samples (40%) haddetectable concentrations ofall opiates tested. Significant correlations (p < 0.0001) werefound between AC and 6-MAM (r =0.95), heroin and6·MAM (r =0.81), and heroin and AC (r = 0.84). Although noneof the subjects in this study werebeing treated with prescription heroin, nine showed detectable concentrations of heroin with nodetectable AC. The mean concentration of heroin in these lattersamples was very low compared with samples showing detectable AC (24 vs, 2571 pg/t), Several studies have reported the usefulness of measuring AC in urine for detection of illicit heroin abuse. This study demonstrates that the same marker canalsobe applied to oral fluid. The additional measurement of heroin in oralfluid isof limited usein monitoring subjects attending a substance abuse clinic.
Introduction
The investigation ofheroin abuse presently relies upon the detection ofthe metabolites 6-monoacetylmorphine (6-MAM) and morphine inavariety ofbiological fluids orinhair analysis. The problems in relation to these metabolites in detecting heroin abuse are well known. Whereas 6-MAM is a specific metabolite ofheroin (diacetylmorphine), morphine may be detectable asa result ofingestion ofpoppy seed-containing foods (1, 2) , from metabolism ofcodeine (3), or from administration ofmorphine itself. The very short half life of6-MAM can also be a disadvantage in samples that only show detectable concentrations of morphine. Afurther problem occurs in distinguishing the use of illicit heroin from prescription heroin.
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Pharmaceutical-grade heroin is being prescribed to some patients inmaintenance programs inseveral countries, including Britain, Switzerland, and Germany. Patients on heroin maintenance programs may supplement their treatment with illicit heroin, and a test to determine this abuse is highly desirable. Naturally occurring alkaloids in opium, including noscapine and papaverine, have been suggested aspotential markers for illicit heroin, butthese also occur inpoppy seed-containing foods (4) . The only marker so far found tobe specific for illicit heroin is acetylcodeine (AC). AC arises as an impurity inthesynthesis of illicit heroin, and there have been several reports establishing it as a useful marker for illicit heroin in urine samples (5, 6) . However, oral fluid testing for drugs ofabuse is becoming increasingly popular, particularly with the introduction of methods using liquid chromatography-tandem mass spectrometry (LC-tlS-MS) (7, 8) . Therefore, a method to measure AC in oral fluid and compare this marker with the presence of 6-MAM and morphine in patients who abuse heroin was developed. It was also decided to include the measurement offree heroin inthis study asthere islittle published work onthis drug inany biological matrix.
Materials and Methods

Chemicals and reagents
Drug standards, morphine, 6-acetylmorphine, diacetylmorphine, codeine, and acetylcodeine, and deuterated internal standards, morphine-de fi-acetylrnorphine-dj, and codeine-dj, were purchased from LGC Promochem (Teddington, UK). Ammonium acetate, methanol, acetronitrile, acetone, and propan-2-01 [all high-performance liquid chromatography (HPLC) grade] were supplied by BDH (Lutterworth, U.K.). Formic acid (98% minimum) was from Scientific Laboratory Supplies (Nottingham, UK).
Preparation of routine calibration standards and internal standards
The drug standards were supplied at 1giL ineither methanol or acetronitrile, and separate working stock solutions of 50 mgIL were prepared by dilution of1mL ofthedrug standard in 20 mL ofthe appropriate solvent (methanol oracetronitrile).
Combined drug calibration standards for routine use were prepared by dilution of each working stock solution in 15% methanol in 4 mmol/L ammonium acetate to give a 500 llgIL solution, which was serially diluted to provide calibration standards at 0, 15.6, 31.25, 62.5, 125, 250, and 500 llgIL. The calibration standards were aliquoted (0.5 mL) into glass sample vials and stored at-20°C.
The deuterated internal standards, supplied at 1 gIL or 100 mgIL (in methanol oracetronitrile), were diluted inthe appropriate solvent to give intermediate internal standard stock solutions of20 mgIL. Acombined working internal standard solution was prepared by dilution of500 ul, ofeach intermediate solution in 10 mL ofmethanol and stored at-20°C.
were packed in-house with EXSIL BDS C8 purchased from AlItech (Carnforth, U.K.) and were run on a Shimadzu HPLC system (Milton Keynes, U.K.), oven temperature 35°C. Guard columns (C8, 4 mm x 2 mm) were obtained from Phenomenex (Macclesfield, U.K.). Samples were loaded inmobile phase A(5% methanol in 4mM ammonium acetate) and eluted in mobile phase B(1%propan-z-ol and 0.05% formic acid in methanol) at a flow rate of0.8 ml/min, using the following gradient elu- • Transitions given in italics were used for confirmation. 
Oral fluid collection
Oral fluid samples (11 =513) were collected from subjects attending drugs ofabuse clinics and analyzed within one day of collection. None ofthe patients attending this clinic were ona heroin replacement program. Oral fluid was collected using the Intercept" specimen collection device (OraSure Technologies, Bethlehem, PAl. Amixture ofsaliva, gingival crevicular fluid, and mucosal transudate isabsorbed onto a collection swab that isplaced between the gum ofthe upper or lower jaw and the inside ofthe cheek for 2 min. The swab isplaced incollection buffer to elute the drugs, and the collection buffer/oral fluid solution istransferred toclean tubes by centrifugation at 2000 xg for 15 min. The buffer supplied with the collection devices was found tobe unsuitable for the measurement ofdrugs by LC-MS-MS because ofthe presence ofthe surfactant Tween 20; it was therefore replaced with 15% methanol in4 mmol/L ammonium acetate. Collection of oral fluid into this buffer system resulted in an approximate 1:3 dilution, and all measured drug concentrations were adjusted back tothe approximate original concentration by multiplication by three.
Preparation ofquality control material (QC) Drug-free oral fluid were collected from laboratory volunteers using the Intercept specimen collection device and pooled. The pooled oral fluid was validated tobe drug free by analysis by LC-MS-MS. These pools were spiked with morphine, codeine, 6-MAM, AC, and heroin at 10, 150, and 500 llgiL concentrations, using thedrug working stock solutions, aliquoted, and stored at-20°C.
LC and MS
Drugs were separated by reversed-phase chromatography and detected by tandem MS (LC-MS-MS). Oral fluid samples were spun at 13,000 xg for 10 min, and 0.5 mL was transferred to glass sample vials. Twenty-five microliters ofthe working internal standard was added toall subject samples, QC samples, and calibration standards, and 50ul,was injected onto the column. Columns (50 x 3.2-mm i.d.) tion profile: 100% mobile phase Afor 1 min, 0 to 95% mobile phase Bover 3 min, 95% mobile phase Bfor 2 min, 95 to 0% B over 0.1 min, then 100% mobile phase Afor 1 min. The first 2 min ofeach chromatographic runwere diverted towaste.
MS was performed onanApplied Biosystems/MDS Sciex API 3000 tandem MS equipped with a Turbo-lon-Spray source (Applied Biosysterns, Warrington, Cheshire, U.K.). The electrospray source was operated inpositive ion mode with a temperature of475°C and a spray voltage of5000V. The nebulizer and curtain gas flow were setto 10 I/min, the collision gas flow to 9 Umin, and cone voltage and collision energy were auto-optimized for each drug. Multiple reaction monitoring was used for the detection ofeach drug using the transitions given inTable I. Quantitation was carried out using Analyst Software v1.3 (Applied Biosystems) and was based on the peak-area ratio of each drug to their respective internal standard (morphine-d, was used as theinternal standard for AC and heroin). Calibration curves for each drug were produced oneach runusing the calibration standards (0-500 J.1g1L). For 6-MAM, morphine, heroin, and acetylcodeine, samples with measured drug concentrations above 1000 J.1g1L (upper limit ofassessed linearity) were suitably diluted tofall within the calibration range and reanalyzed. Because of the quadratic calibration curve used for codeine quantitation, samples were diluted and reanalyzed whencodeine concentrations were above 500 J.1g/L (upper calibration point).
Assay validation
Linearity wasanalyzed using aneight-point calibration curve for each drug over the concentration range 0-1000 J.1g/L. Reproducibility and accuracy were determined by the repeat analysis ofQC material (n =8). The limit ofdetection (LOD) was determined as the lowest concentration of spiked oral fluid yielding a signal-to-noise ratio of>3 and the limit ofquantitation (LOQ) as the lowest concentration with a signal-to-noise ratio >10.
Statistical analysis
All statistical analysis was carried out using Analyse-it'" for Microsoft®Excel (Leeds, U.K.). For the Pearsons correlation analysis, all data was !OglO transformed to give a normal distribution. Results Linearity, precision, accuracy, and analytical limits for 6-MAM, morphine, AC, heroin, and codeine are listed inTable II. 6-MAM, morphine, AC, and heroinwere all linear over thecalibration range (0-1000 J.1g/L), whereas a quadratic curve gave the best fitfor codeine. The coefficient ofcorrelation (r 2 ) was> 0.995 for each opiate. Within-batch precision was generally within accepted limits (CV < 15%) for all the opiates at each concentration level; however, between-batch data showed greater imprecision (CV < 20%). Exceptions were heroin, which had high within-and between-batch imprecision at 10 J.1g/L (CV = 30% and 39%, respectively), and AC, which had a higher between-batch imprecision at thelow concentration level (CV = 25%). The assigned LOQ values were used ascutoff concentrations throughout the rest ofthe study.
I.DOes
The oral fluid samples were analyzed in 10 separate batches over a 2-month period for morphine, 6-MAM, AC, heroin, and codeine. Atotal of297 (58%) tested positive for one or more of the opiates. Atypical chromatogram for a sample positive for all opiates is shown in Figure 1 . Mean and median and range of concentrations for each ofthe opiates in positive samples are shown inTable III. The much lower median values compared to the mean are indicative ofnegatively skewed data for all opiates detected. Morphine was the most prevalent (97%) metabolite found intheopiate-positive sample group, followed very closely by codeine (8!%) and 6-MAM (77%). AC and heroin were found to be detectable in 55% and 45%, respectively, of the overall opiate-positive samples. The distribution pattern ofeach opiate inthepositive samples isshown inTable IV.
The large percentage (43%) of opiate-positive samples showing the presence of both heroin and all metabolites as well as thepresence ofAC reflects the population being studied (i.e., addicts attending a substance abuse clinic). Nine samples were found tocontain heroin butwith no detectable AC; however, the levels ofheroin inthese samples was comparatively low (concentration mean 24 J.1g/L) compared to heroin found in AC-positive samples (concentration mean 2571 J.1g/L). None of these patients were being treated with pharmaceutical-grade heroin (diacetylmorphine).
Asignificant correlation was found (P < 0.0001) between AC and 6-MAM and heroin and 6-MAM (Figures 2A and 2B , respectively). All samples positive for both AC and heroin had detectable concentrations of6-MAM. AC was notdetected inany samples where the 6-MAM concentration was < 30 J.1g1L. A wider degree ofscatter was observed between heroin and 6-MAM compared toAC and 6-MAM, with 90% ofsamples positive for heroin having a 6-MAM concentration> 70 J.1g/L. Apositive correlation was also observed between heroin and AC (p < 0.0001) ( Figure 2C ).
Discussion
The detection ofAC inbiological fluids will depend upon several factors, including thedose ofheroin and itscontent ofAC, timing of the sample, limit of quantitation of the assay, in- traindividual variations in metabolism, and excretion of AC into thebiological matrix. Previous studies ofAC have been carried outin urine, and there are nopublished studies inrelation tooral fluid. O'Neal and Poklis (5) and Staub et aJ. (6) used gas chromatography-Me and found a correlation between AC and 6-MAM inurine (r = 0.878 and 0.702, respectively). However, a much better correlation was observed between AC and 6-MAM in this study using oral fluid as the matrix (r = 0.95). The detection ofAC in urine samples positive for 6-MAM differed considerably between both urine studies with the former study reporting detectable AC in only 37% of6-MAM-positive urine samples compared with a much higher incidence (85.9%) inthe latter urine study. This compares to a 70% occurrence ofACpositive results in6-MAM-positive oral fluid samples. The range ofAC inoral fluid (3-15,150 j.Ig1L) was much greater than that reported in both urine studies (2-290 and 3-2710 j.Ig1L, respectively), and thepercentage ofAC compared to 6-MAM was higher inoral fluid (10%) compared with thatreported inurine (2.2%). Although the measured detection time ofAC in urine has been shown to be very similar to that of 6-MAM (6,9), both previous urine studies show 6-MAM to be a better indicator of heroin abuse than AC. However, both studies indicate thatAC could be a useful marker indetection of illicit heroin abuse in addicts in heroin maintenance programs. O'Neal and Poklis (5) do point out thatAC isa much less reliable marker for illicit heroin abuse than 6-MAM in workplace or criminal justice urine screening programs, where drug concentrations may be much lower than observed insubstance abuse clinics. This study also demonstrates theusefulness ofAC in oral fluid in the pies in opiate-positive oral fluid samples. The concentration range of heroin detected in oral fluid (10-44,100 )lglL) was greater than that reported inurine (4-10,265 )lgIL) and may reflect heroin contamination ofthe oral cavity after inhalation of the drug. Although this study has demonstrated thatheroin is detectable in oral fluid at high levels, the variability ofheroin content in6-MAM-positive samples and high LOQ for the assay suggest thatthe measurement ofheroin inoral fluid may be of limited use in monitoring subjects attending drugs ofabuse clinics. 
